CANC ETF (Tema Oncology ETF) is managed by Tema Global Limited with $196.9M in net assets. CANC expense ratio is 0.75%, holding 56 positions across sectors including Health Care, Unknown, Other. Inception date: 2023-08-15.

CANC performance shows a YTD return of 18.72%. The 1-year return is 66.34%. CANC dividend yield stands at 0.05%, paid annually.

CANC top holdings include Revolution Medicines Inc Ser C Pc Pp (7.2%), Eli Lilly & Co (4.4%), Roche Holding Ag (Adr) (4.2%), Immunome Inc (4.1%), Novartis Ag (4.1%). View all CANC holdings, sector breakdown, or dividend history.

CANC can be compared against other funds using the overlap calculator or side-by-side comparison tool. CANC alternatives are available via the screener, along with tax-loss harvesting opportunities.